K
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Recent Filings
- 8-K325.7 KBKaruna Therapeutics, Inc.Mar 18, 9:04 AM ET·0001140361-24-013728
- 10-K/A6.5 MBKaruna Therapeutics, Inc.Mar 14, 4:16 PM ET·0000950170-24-031505
- 8-K168.8 KBKaruna Therapeutics, Inc.Mar 14, 7:26 AM ET·0001140361-24-013155
- 8-K177.6 KBKaruna Therapeutics, Inc.Mar 12, 4:15 PM ET·0001140361-24-012807
- 8-K343.6 KBKaruna Therapeutics, Inc.Mar 1, 6:01 AM ET·0001140361-24-010584
- 10-K16.0 MBKaruna Therapeutics, Inc.Feb 22, 6:39 AM ET·0000950170-24-018395
- 8-K300.1 KBKaruna Therapeutics, Inc.Feb 22, 6:32 AM ET·0000950170-24-018393
- SC 13G6.5 KBKaruna Therapeutics, Inc.Feb 14, 10:04 AM ET·0001897612-24-001265
- SC 13G/A6.5 KBKaruna Therapeutics, Inc.Feb 14, 10:03 AM ET·0000080255-24-000743
- SC 13G/A13.0 KBKaruna Therapeutics, Inc.Feb 13, 5:08 PM ET·0001104659-24-021271
Insiders
10- Alexandria Venture Investments, LLC10% Owner
- ARCH Venture Fund IX, L.P.10% Owner
- ARCH Venture Partners IX, LLC10% Owner
- ARCH Venture Partners IX, L.P.10% Owner
- Brannan Stephen K.Chief Medical Officer
- Brown Jason ParkerChief Financial Officer
- BYBEE CLINTON10% Owner
- CHOWRIRA BHARAT MDirector
- COUGHLIN CHRISTOPHER JDirector
- CRANDELL KEITH10% Owner
Tickers
No tickers on record
Addresses
business
99 HIGH STREET 26TH FLOOR
BOSTON, MA, 02110
mailing
99 HIGH STREET 26TH FLOOR
BOSTON, MA, 02110